Article Versions Notes

Choi UY, Kim KH, Cho H-K, Kim DH, Ma SH, Choi YY, Kim CS, Capeding MR, Kobashi IAR, Kim H, et al. Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study. Vaccines. 2023; 11(9):1416. https://doi.org/10.3390/vaccines11091416

Choi, Ui Yoon, Ki Hwan Kim, Hye-Kyung Cho, Dong Ho Kim, Sang Hyuk Ma, Young Youn Choi, Chun Soo Kim, Maria Rosario Capeding, Ilya Angelica Rochin Kobashi, Hun Kim, and et al. 2023. "Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study" Vaccines 11, no. 9: 1416. https://doi.org/10.3390/vaccines11091416

Choi, U. Y., Kim, K. H., Cho, H.-K., Kim, D. H., Ma, S. H., Choi, Y. Y., Kim, C. S., Capeding, M. R., Kobashi, I. A. R., Kim, H., Ryu, J. H., Lee, S. J., Park, H. K., & Kim, J.-H. (2023). Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study. Vaccines, 11(9), 1416. https://doi.org/10.3390/vaccines11091416